Skip to main content
EANM Journals

EANM Alavi-Carlsen Award

Find out more about our new award! 

EANM / Publications / EANM Journals / EANM Alavi-Carlsen Award

EANM Alavi-Carlsen Award

Following the launch of our new EANM journals in August 2025, we proudly launched the EANM Alavi-Carlsen Award.

Aim:

The EANM Alavi-Carlsen Award recognises outstanding publications in one of the two EANM journals by young professionals under the age of 38 at the time of publication.

Eligibility:
  • The research must be published in one of the EANM journals (The EANM Journal or EANM Innovation) in the calendar year before the award is granted.
  • The first or corresponding author must be a nuclear medicine scientist younger than 38 years at the time of publication.
  • Only original research articles are eligible (reviews, guidelines, position papers, editorials, or “hotspot” articles are excluded).
Prize:

For each journal, one prize of €4,000 will be awarded. The prize must be used for scientific development or training within institutions in Europe.

Process:

When submitting their research to the EANM journals, authors will have the option to indicate their interest in being considered for the award directly in the Editorial Manager system.

A dedicated jury of EANM experts, including the Editors-in-Chief of the EANM journals, will evaluate all eligible submissions. Two winners will be selected each year – one per journal.

The winners will be presented at the EANM’26 congress.

Background:

Apart from supporting young scientists in nuclear medicine research, the award honours the legacy of two pioneers who have shaped the field: Abass Alavi and Poul Flemming Høilund-Carlsen.

With a career spanning more than five decades, Alavi spent most of his time at the University of Pennsylvania, becoming one of the most influential figures in the history of medical imaging. Høilund-Carlsen is likewise a leading voice in nuclear medicine, known for advancing PET/CT imaging through both innovation and critical debate on the interpretation and application of imaging in clinical practice.

You can find out more about them and how they have shaped the field here.

Questions:

If you have any questions about the EANM Alavi-Carlsen Award, don’t hesitate to reach out to us at editorial.office@eanm.org.

Overview over past winners

Vienna 2026

The EANM Journal

BETA PLUS Study Phase 0b: Effect of Peptide Mass on Safety, Dosimetry, and Preliminary Efficacy of [¹⁶¹Tb]Tb-DOTA-LM3 in Metastatic GEP-NET (G1-2)

Matthias Miederer, Sebastian Hoberück, Tobias Holscher, Christian Thomas,Caner Civan, Thanusiah Selvamoorthy, Martin Stuschke, Lale Umutlu, Kambiz Rahbarj, Martin Bogemann, Michael Schafers, Andrew Nguyen, Lela Theusl, Dominic Ufton, Jolanta Kunikowska m, Francesco Lanfranchi, Andrej Vondrak, Caroline Alionte, Gabriel T. Sheikh, Adrien Holzgreve, Isabel Rauscherr, Matthias Eiberr, Claudia Kesch, Ken Herrmann, Boris A. Hadaschik, Wolfgang P. Fendlerf, Madeleine J. Karpinski 

Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany, Department of Translational Imaging in Oncology, National Center for Tumour Diseases (NCT/UCC) Dresden: a partnership between German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany, Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany, Department of Urology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany, Department of Nuclear Medicine, DKTK and NCT University Hospital Essen, Essen, Germany, Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany, Department of Radiotherapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany, Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany, Department of Nuclear Medicine, University Hospital Münster and West German Cancer Center, Münster, Germany, Department of Urology and Urooncology, University Hospital Münster and West German Cancer Center, Münster, Germany, Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA, Nuclear Medicine Department, Medical University Warsaw, Warsaw, Poland, Department of Experimental Medicine (DIMES), University of Genova, Genova, Italy, IZOTOPCENTRUM, s.r.o, Nuclear Medicine Department, Nitra, Slovakia, Schulich School of Medicine and Dentistry, Western University, Ontario, Canada, Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany, Department of Nuclear Medicine, School of Medicine and Health, TUM University Hospital, Munich, Germany, Department of Urology, University Hospital Essen, Essen, Germany


EANM Innovation

Q amyloid: an open platform for quantitative Aβ PET imaging

Benedetta Marin, Francesco Piva, Chiara Da Villa, Ludovico Luchetti, Giacomo Demurtas, Lucia Maccioni, Manuela Moretto, Luigi Lorenzini,
Marco Battaglini, Mattia Veronese

Department of Information Engineering, University of Padua, Padua, Italy, Siena Imaging S.r.l., Siena, Italy, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy, Department of Neuroimaging, King’s College London, London, UK, Department of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands, Amsterdam Neuroscience, Neuroimaging, Amsterdam, the Netherlands



We also had the pleasure of recognising Seyed Ali Mirshahvalad (The EANM Journal) and Bart Cornelissen (EANM Innovation) with the Best Reviewer Award, and Giorgio Treglia (The EANM Journal) and Silvia Morbelli (EANM Innovation) with the Fastest Reviewer Award.

© Faistauer Photography